BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18688064)

  • 1. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.
    Lee MS; Pessegueiro A; Zimmer R; Jurewitz D; Tobis J
    J Invasive Cardiol; 2008 Aug; 20(8):401-3. PubMed ID: 18688064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bare metal stent restenosis is not a benign clinical entity.
    Chen MS; John JM; Chew DP; Lee DS; Ellis SG; Bhatt DL
    Am Heart J; 2006 Jun; 151(6):1260-4. PubMed ID: 16781233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
    Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
    J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon?
    Bainey KR; Norris CM; Graham MM; Ghali WA; Knudtson ML; Welsh RC;
    Int J Cardiol; 2008 Aug; 128(3):378-82. PubMed ID: 17689711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.
    Li Y; Torguson R; Syed AI; Ben-Dor I; Collins SD; Maluenda G; Scheinowitz M; Kaneshige K; Xue Z; Lemesle G; Satler LF; Suddath WO; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Dec; 104(12):1654-9. PubMed ID: 19962470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention with drug-eluting stents in octogenarians: characteristics, clinical presentation, and outcomes.
    Hassani SE; Wolfram RM; Kuchulakanti PK; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):36-43. PubMed ID: 16764007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular brachytherapy for patients with drug-eluting stent restenosis.
    Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stent fracture and acute coronary syndrome.
    Chhatriwalla AK; Cam A; Unzek S; Bhatt DL; Raymond RE; Lincoff AM; Whitlow PL; Ellis SG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2009; 10(3):166-71. PubMed ID: 19595398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical presentation of restenosis after bare metal stent implantation: behind a facade of benignity.
    Celik T; Iyisoy A; Yuksel C; Jata B; Isik E
    Int J Cardiol; 2009 Jul; 135(3):401-3. PubMed ID: 18571254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
    Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW;
    Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
    Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
    Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
    Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
    Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction.
    Kornowski R; Vaknin-Assa H; Lev E; Ben-Dor I; Teplitsky I; Rechavia E; Brosh D; Fuchs S; Assali A
    Acute Card Care; 2008; 10(3):167-72. PubMed ID: 18803074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
    Ponnuthurai FA; van Gaal WJ; Channon KM
    J Invasive Cardiol; 2007 Dec; 19(12):E369-71. PubMed ID: 18180530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
    Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
    Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.